Although technical limitations cannot be excluded, the presence of CLL B cell markers such as CD5, CD19 and CD20 suggest these cells to be a clonal B cell population with a CLL phenotype. This evidence concerns the gene CD5 and B-cell chronic lymphocytic leukemia.